Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (97)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Fukutake, M.
Right arrow Articles by Wakabayashi, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fukutake, M.
Right arrow Articles by Wakabayashi, K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol 19, 1939-1942, Copyright © 1998 by Oxford University Press

ARTICLES

Suppressive effects of nimesulide, a selective inhibitor of cyclooxygenase-2, on azoxymethane-induced colon carcinogenesis in mice

M Fukutake, S Nakatsugi, T Isoi, M Takahashi, T Ohta, S Mamiya, Y Taniguchi, H Sato, K Fukuda, T Sugimura and K Wakabayashi
Cancer Prevention Division, National Cancer Center Research Institute, Tokyo, Japan.

The effects of nimesulide, a selective inhibitor of cyclooxygenase-2 (COX-2) on azoxymethane (AOM)-induced colon carcinogenesis were investigated in mice. AOM at a dose of 10 mg/kg body wt was administered to male ICR mice once a week for 6 weeks. The animals were fed on AIN-76A powder diet containing nimesulide at doses of 200 or 400 p.p.m., starting the day before the first carcinogen treatment until the end of the experiment, at week 30. Administration of nimesulide reduced the incidence of colon carcinomas to 32 and 25% for the AOM + 200 and 400 p.p.m. nimesulide groups, respectively, compared with the AOM + basal diet group (50%). Multiplicities of colon carcinomas in the 200 and 400 p.p.m. nimesulide-treated groups were 0.70 +/- 0.28 and 0.35 +/- 0.11, respectively, being significantly smaller than the AOM alone value (1.79 +/- 0.47). The sizes of the colon carcinomas in the nimesulide-treated groups were also decreased. No significant influence on liver and lung tumor development was apparent. Thus, nimesulide exerted a suppressive effect on AOM-induced colon carcinogenesis in mice.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cancer Res.Home page
A. P. Fields, S. R. Calcagno, M. Krishna, S. Rak, M. Leitges, and N. R. Murray
Protein Kinase C{beta} Is an Effective Target for Chemoprevention of Colon Cancer
Cancer Res., February 15, 2009; 69(4): 1643 - 1650.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
S. Y. Nam, J. S. Kim, J. M. Kim, J. Y. Lee, N. Kim, H. C. Jung, and I. S. Song
DA-6034, a Derivative of Flavonoid, Prevents and Ameliorates Dextran Sulfate Sodium-Induced Colitis and Inhibits Colon Carcinogenesis
Experimental Biology and Medicine, February 1, 2008; 233(2): 180 - 191.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Funahashi, M. Satake, D. Dawson, N.-A. Huynh, H. A. Reber, O. J. Hines, and G. Eibl
Delayed Progression of Pancreatic Intraepithelial Neoplasia in a Conditional KrasG12D Mouse Model by a Selective Cyclooxygenase-2 Inhibitor
Cancer Res., August 1, 2007; 67(15): 7068 - 7071.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
T. E. Riehl, R. J. George, M. A. Sturmoski, R. May, B. Dieckgraefe, S. Anant, and C. W. Houchen
Azoxymethane protects intestinal stem cells and reduces crypt epithelial mitosis through a COX-1-dependent mechanism
Am J Physiol Gastrointest Liver Physiol, December 1, 2006; 291(6): G1062 - G1070.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
R. F. Di Pace, S. Massa, O. G. Ribeiro, W. H. K. Cabrera, M. De Franco, N. Starobinas, M. Seman, and O. C. M. Ibanez
Inverse genetic predisposition to colon versus lung carcinogenesis in mouse lines selected based on acute inflammatory responsiveness
Carcinogenesis, August 1, 2006; 27(8): 1517 - 1525.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
H. Zhi, L. Wang, J. Zhang, C. Zhou, F. Ding, A. Luo, M. Wu, Q. Zhan, and Z. Liu
Significance of COX-2 expression in human esophageal squamous cell carcinoma
Carcinogenesis, June 1, 2006; 27(6): 1214 - 1221.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. Fux, M. Schwab, K.-P. Thon, C. H. Gleiter, and P. Fritz
Cyclooxygenase-2 Expression in Human Colorectal Cancer Is Unrelated to Overall Patient Survival
Clin. Cancer Res., July 1, 2005; 11(13): 4754 - 4760.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
Y. Zeng, M. Yokohira, K. Saoo, H. Takeuchi, Y. Chen, K. Yamakawa, Y. Matsuda, Y. Kakehi, and K. Imaida
Inhibition of prostate carcinogenesis in probasin/SV40 T antigen transgenic rats by raloxifene, an antiestrogen with anti-androgen action, but not nimesulide, a selective cyclooxygenase-2 inhibitor
Carcinogenesis, June 1, 2005; 26(6): 1109 - 1116.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. R. Brown and R. N. DuBois
COX-2: A Molecular Target for Colorectal Cancer Prevention
J. Clin. Oncol., April 20, 2005; 23(12): 2840 - 2855.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
Y Shoji, M Takahashi, T Kitamura, K Watanabe, T Kawamori, T Maruyama, Y Sugimoto, M Negishi, S Narumiya, T Sugimura, et al.
Downregulation of prostaglandin E receptor subtype EP3 during colon cancer development
Gut, August 1, 2004; 53(8): 1151 - 1158.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
M. A. Hull, S. C.W. Ko, and G. Hawcroft
Prostaglandin EP receptors: Targets for treatment and prevention of colorectal cancer?
Mol. Cancer Ther., August 1, 2004; 3(8): 1031 - 1039.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
G. J. Kelloff, R. L. Schilsky, D. S. Alberts, R. W. Day, K. Z. Guyton, H. L. Pearce, J. C. Peck, R. Phillips, and C. C. Sigman
Colorectal Adenomas: A Prototype for the Use of Surrogate End Points in the Development of Cancer Prevention Drugs
Clin. Cancer Res., June 1, 2004; 10(11): 3908 - 3918.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. S. Shaik, A. Chatterjee, and M. Singh
Effect of a Selective Cyclooxygenase-2 Inhibitor, Nimesulide, on the Growth of Lung Tumors and Their Expression of Cyclooxygenase-2 and Peroxisome Proliferator- Activated Receptor-{gamma}
Clin. Cancer Res., February 15, 2004; 10(4): 1521 - 1529.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
M. Dong, K. Guda, P. R. Nambiar, A. Rezaie, G. S. Belinsky, G. Lambeau, C. Giardina, and D. W. Rosenberg
Inverse association between phospholipase A2 and COX-2 expression during mouse colon tumorigenesis
Carcinogenesis, February 1, 2003; 24(2): 307 - 315.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
T. Kitamura, T. Kawamori, N. Uchiya, M. Itoh, T. Noda, M. Matsuura, T. Sugimura, and K. Wakabayashi
Inhibitory effects of mofezolac, a cyclooxygenase-1 selective inhibitor, on intestinal carcinogenesis
Carcinogenesis, September 1, 2002; 23(9): 1463 - 1466.
[Abstract] [Full Text] [PDF]

Home page
 Integr Cancer TherHome page
J. M. Wallace
Nutritional and Botanical Modulation of the Inflammatory Cascade--Eicosanoids, Cyclooxygenases, and Lipoxygenases-- As an Adjunct in Cancer Therapy
Integr Cancer Ther, March 1, 2002; 1(1): 7 - 37.
[Abstract] [PDF]

Home page
 CarcinogenesisHome page
A. Denda, W. Kitayama, A. Murata, H. Kishida, Y. Sasaki, O. Kusuoka, T. Tsujiuchi, M. Tsutsumi, D. Nakae, H. Takagi, et al.
Increased expression of cyclooxygenase-2 protein during rat hepatocarcinogenesis caused by a choline-deficient, L-amino acid-defined diet and chemopreventive efficacy of a specific inhibitor, nimesulide
Carcinogenesis, February 1, 2002; 23(2): 245 - 256.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Mutoh, K. Watanabe, T. Kitamura, Y. Shoji, M. Takahashi, T. Kawamori, K. Tani, M. Kobayashi, T. Maruyama, K. Kobayashi, et al.
Involvement of Prostaglandin E Receptor Subtype EP4 in Colon Carcinogenesis
Cancer Res., January 1, 2002; 62(1): 28 - 32.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
T. Kawamori, N. Uchiya, S. Nakatsugi, K. Watanabe, S. Ohuchida, H. Yamamoto, T. Maruyama, K. Kondo, T. Sugimura, and K. Wakabayashi
Chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP1 antagonist, on breast cancer development
Carcinogenesis, December 1, 2001; 22(12): 2001 - 2004.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
D. A. Maria, O. G. Ribeiro, K. F. Pizzocaro, M. De Franco, W. K. Cabrera, N. Starobinas, V. Gallois, M. Siqueira, M. Seman, and O. M. Ibanez
Resistance to melanoma metastases in mice selected for high acute inflammatory response
Carcinogenesis, February 1, 2001; 22(2): 337 - 342.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Shiotani, A. Denda, K. Yamamoto, W. Kitayama, T. Endoh, Y. Sasaki, M. Tsutsumi, M. Sugimura, and Y. Konishi
Increased Expression of Cyclooxygenase-2 Protein in 4-Nitroquinoline-1-oxide-induced Rat Tongue Carcinomas and Chemopreventive Efficacy of a Specific Inhibitor, Nimesulide
Cancer Res., February 1, 2001; 61(4): 1451 - 1456.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
J. W. Wilson and C. S. Potten
The Effect of Exogenous Prostaglandin Administration on Tumor Size and Yield in Min/+ Mice
Cancer Res., August 1, 2000; 60(16): 4645 - 4653.
[Abstract] [Full Text]

Home page
 CarcinogenesisHome page
M. Takahashi, S. Nakatsugi, T. Sugimura, and K. Wakabayashi
Frequent mutations of the {beta}-catenin gene in mouse colon tumors induced by azoxymethane
Carcinogenesis, June 1, 2000; 21(6): 1117 - 1120.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
H. Sasai, M. Masaki, and K. Wakitani
Suppression of polypogenesis in a new mouse strain with a truncated Apc{Delta}474 by a novel COX-2 inhibitor, JTE-522
Carcinogenesis, May 1, 2000; 21(5): 953 - 958.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
M. Mutoh, M. Takahashi, K. Fukuda, Y. Matsushima-Hibiya, H. Mutoh, T. Sugimura, and K. Wakabayashi
Suppression of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells by chemopreventive agents with a resorcin-type structure
Carcinogenesis, May 1, 2000; 21(5): 959 - 963.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
D. Tardieu, J.-P. Jaeg, A. Deloly, D. E. Corpet, J. Cadet, and C. R. Petit
The COX-2 inhibitor nimesulide suppresses superoxide and 8-hydroxy-deoxyguanosine formation, and stimulates apoptosis in mucosa during early colonic inflammation in rats
Carcinogenesis, May 1, 2000; 21(5): 973 - 976.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Kondo, H. Yamamoto, H. Nagano, J. Okami, Y. Ito, J. Shimizu, H. Eguchi, A. Miyamoto, K. Dono, K. Umeshita, et al.
Increased Expression of COX-2 in Nontumor Liver Tissue Is Associated with Shorter Disease-free Survival in Patients with Hepatocellular Carcinoma
Clin. Cancer Res., December 1, 1999; 5(12): 4005 - 4012.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.